Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

ASTELLAS PHARMA INC (4503)

10
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ASTELLAS PHARMA INC
03/27 MEDIVATION : and Astellas Release New Enzalutamide Data
03/27 ASTELLAS PHARMA INC : ex-dividend day for final dividend
03/24 ASTELLAS PHARMA : AND MEDIVATION ANNOUNCE NEW ENZALUTAMIDE DATA PRESENTED DURING..
03/23 ASTELLAS PHARMA : - announcement of marketing approval submission to mhlw (japan..
03/20 ASTELLAS PHARMA : Announcement of marketing approval submission to mhlw (japan) ..
03/18 ASTELLAS PHARMA : New Drug Administration Routes Findings Has Been Reported by R..
03/17 ASTELLAS PHARMA : - Notice of Completion of Acquisition of Own Shares (Under the..
03/17 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Kiklin® Capsules..
03/15 ASTELLAS PHARMA : Receives FDA Approval for CRESEMBA® (isavuconazonium sulfate) ..
03/15 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 62 KB)
03/11 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Broaden Understanding of D..
03/10 ASTELLAS PHARMA : Immunomic Therapeutics to Present at BIO-Europe Annual Confere..
03/09 ASTELLAS PHARMA : Basilea reports U.S. FDA approval of isavuconazole for the tre..
03/08 ASTELLAS PHARMA : FDA Approves New Antifungal Drug Cresemba
03/06 ASTELLAS PHARMA : FDA approves Astellas drug for serious fungal infections
03/04 ASTELLAS PHARMA : Patent Issued for Tetrahydroisoquinoline Derivative
03/04 ASTELLAS PHARMA : Data on Non-Small Cell Lung Cancer Described by Researchers at..
03/04 ASTELLAS PHARMA : and BlackDoctor.org BDO Team Up to Offer Health Education at t..
03/04 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Yields New Findings on Alz..
03/04 ASTELLAS PHARMA : Recent Research from Astellas Pharma, Inc. Highlight Findings ..
03/04 ASTELLAS PHARMA INC : Antibiotic Croissants; How Matinas Could Revolutionize the..
03/03 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares - (Under the pro..
03/02 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 63KB)
02/27 CYTOKINETICS : Joins Global Movement to Raise Awareness for Rare Diseases
02/26 ASTELLAS PHARMA : Medivation Reports Fourth Quarter and Full Year 2014 Financial..
02/26 ASTELLAS PHARMA : Cytokinetics Announces Publication of Preclinical Data Relatin..
02/26 ASTELLAS PHARMA : and BDO Partner
02/25 ASTELLAS PHARMA : and BDO Partner
02/23 ASTELLAS PHARMA : and BlackDoctor.org (BDO) Team Up to Offer Health Education at..
02/19 ASTELLAS PHARMA : Recent Findings from Astellas Pharma, Inc. Provides New Insigh..
02/19 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Yield New Data on Pharmacok..
02/16 ASTELLAS PHARMA : Launches the Newest Element in its Global Corporate Brand Camp..
02/13 ASTELLAS PHARMA : Launches the Newest Element in its Global Corporate Brand Camp..
02/12 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Broaden Understanding of C..
02/11 ASTELLAS PHARMA : New Pharmacokinetics Study Findings Have Been Reported by Rese..
02/11 ASTELLAS PHARMA : Broadens Commitment to Clinical Trial Data Transparency
02/09 ASTELLAS PHARMA : Enhancement of Astellas' Management Structure
02/05 ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes (pdf 98KB..
02/05 ASTELLAS PHARMA : Enhancement of Astellas' Management Structure (pdf 82KB)
02/04 ASTELLAS PHARMA : and Immunomic Therapeutics Announce Exclusive License for JRC2..
02/04 ASTELLAS PHARMA : Researchers at Astellas Pharma, Inc. Target Medicinal Chemistr..
02/04 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Provide New Insights into H..
02/03 ASTELLAS PHARMA : Broadens Commitment to Clinical Trial Data Transparency
02/03 ASTELLAS PHARMA : Announces Acquisition of Own Shares(Under the provision of its..
02/02 ASTELLAS PHARMA : and Immunomic Therapeutics Announce Exclusive License for JRC2..
02/01 ASTELLAS PHARMA : Broadens commitment to clinical trial data transparency
02/01 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 62 KB)
02/01 ASTELLAS PHARMA : Graduate School of Medicine/Faculty of Medicine, Osaka Univers..
01/30 ASTELLAS PHARMA : to develop Immunomic's JRC2-LAMP-vax to treat Japanese red ced..
01/30DJValeant to Buy Prostate-Cancer Drug From Dendreon
01/29DJValeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
01/29 ASTELLAS PHARMA : and Immunomic Therapeutics Announce Exclusive License for JRC2..
01/29 ASTELLAS PHARMA : Study Data from Astellas Pharma, Inc. Update Knowledge of Proi..
01/29 MEDIVATION : and Astellas Pharma Reports Results from Phase 2 Terrain Trial
01/28 ASTELLAS PHARMA : New Chemometrics Findings from Astellas Pharma, Inc. Described..
01/28 MEDIVATION : and Astellas Pharma Releases Results from Phase 2 Terrain Trial
01/23 MEDIVATION : Astellas -enzalutamide phase 2 terrain trial demonstrated statistic..
01/22 ASTELLAS PHARMA : Announces FDA Anti-Infective Drugs Advisory Committee Recommen..
01/14 ASTELLAS PHARMA : Partners With Society of Cardiovascular Patient Care To "Bring..
01/14 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Describe Recent Advances in..
01/08 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Highlight Recent Findings i..
01/01 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in the Area of Clinica..
01/01 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Provide New Data on Type 2 ..
2014 CYTOKINETICS : And astellas announce expansion of collaboration for development ..
2014 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in the Area of Clinica..
2014 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Provide New Data on Type 2 ..
2014 ASTELLAS PHARMA : Cytokinetics and Astellas Announce Expansion of Collaboration ..
2014 MEDIVATION : Data presented from phase 2 study of enzalutamide in advanced andro..
2014 ENUMERAL BIOMEDICAL : Appoints Robert L. Van Nostrand to its Board of Directors
2014 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Provide New Insights into ..
2014 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Has Provided New Data on H..
2014 ASTELLAS PHARMA : Data to be presented from phase 2 study of enzalutamide in adv..
2014 ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index for the Third Year
2014 ASTELLAS PHARMA : to end license agreement with Janssen for ASP015K inhibitor
2014 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in Tinea pedis Provide..
1  2  3  4  5  6Next
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF